New details about the way this important molecule takes on tasks beyond sensing calcium could spur the develop of new drugs for breast cancer and other diseases.
BeatProfiler, a new research tool invented by Columbia bioengineers with the help of AI, speeds and simplifies the analysis of engineered heart tissue in the laboratory.
Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
People with moderate or severe pain have a 41 percent higher risk of developing prescription opioid use disorders, researchers at Columbia University Medical Center have found.
Intranasal flu vaccines may provide long-lasting protection against pandemic flu strains, according to a study from immunologists at Columbia University Medical Center.
Columbia University has received a $58.4 million grant from the NIH's National Center for Advancing Translational Sciences to expand its work in translational research.
CUMC/NYP will serve as a clinical trial site for patients with food allergies as part of the Food Allergy Research & Education (FARE) Clinical Network.
According to a new report published in JAMA Oncology, women with BRCA1 mutations have a higher risk of developing an aggressive type of uterine cancer.
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
Protective traits that once ensured our species’ survival — hunger, thirst, fear, and blood clotting — are now leading causes of illness and death in industrial societies.